- Joined
- Jul 10, 2014
- Messages
- 23,586
- Reaction score
- 46,339
- Points
- 121
Guys later this week I will have liquid TOREM + NOLVA that I personally am manufacturing. The TOREM will prob be 50mgs per ML and the NOLVA will prob be 20mgs per ML. The bottles will be 30 and 60mL and the price range will be 29-59 dollars each depending on the size and compound.
Let me know if you are interested. It will be blended with FOOD GRADE PEG400 but these are super high quality raws that I have had for 2+ years now. It's time to sell them.
Great to remove GYNO and maintain E during PCT.
I will make a link in this thread when they are both here. GENERIC LABELS but very high quality goods. I can't keep Nolva or Ralox in stock so Im gonna just brew up my own raws for you guys and honestly Im gonna jump on 20mgs of the Nolva ed myself. Its good stuff. Refrigerate if you wish. SHAKE MEGA WELL before each and every use.
In cytosols derived from human breast adenocarcinomas, tamoxifen competes with estradiol for estrogen receptor protein.
www.GYMnTONIC.com
Toremifene: Usually dosed around 60 mgs, some dose it up to 240 mgs. Its androgenicity:estrogenicity ratio is 5x that of Nolvadex. It is prescribed to female patients for breast cancer and has shown a high affinity for bonding to the Estrogen receptors in the breast tissue. Male patients treated with toremifene citrate 80 mg compared to placebo demonstrated statistically significant increases in bone mineral density in the lumbar spine, hip, and femur skeletal sites. It decreased the risk by up to 50%. Toremifene citrate 80 mg treatment compared to placebo also resulted in a decrease in total cholesterol, LDL, and triglycerides, and an increase in HDL. There were also statistically significant improvements in gynecomastia. This data are from an ongoing study of men receiving treatment for ADT (androgen depravation therapy). These men are receiving ADT for advanced prostate cancer. ADT removes much of the testosterone and estrogen in the body which helps the prostatic cancer cells grow. So these men were suffering from side effects from reduced estrogen and testosterone in the body. Some studies have even suggested that Torm doesn't regulate progesterone receptors and we may see in the future the possibility of using it with 19-nors.
Toremifene citrate is a selective estrogen receptor modulator (SERM) that is used in bodybuilding to combat gynecomastia and improve muscle growth. It is FDA approved for breast cancer treatment and has shown potential benefits in prostate cancer treatment. Toremifene citrate works by blocking estrogen from interacting with estrogen receptors, leading to an anti-estrogenic effect. This can help prevent gynecomastia and improve muscle growth by maintaining testosterone levels.
Let me know if you are interested. It will be blended with FOOD GRADE PEG400 but these are super high quality raws that I have had for 2+ years now. It's time to sell them.
Great to remove GYNO and maintain E during PCT.
I will make a link in this thread when they are both here. GENERIC LABELS but very high quality goods. I can't keep Nolva or Ralox in stock so Im gonna just brew up my own raws for you guys and honestly Im gonna jump on 20mgs of the Nolva ed myself. Its good stuff. Refrigerate if you wish. SHAKE MEGA WELL before each and every use.
Nolvadex - Clinical Pharmacology
NOLVADEX is a nonsteroidal agent that has demonstrated potent antiestrogenic properties in animal test systems. The antiestrogenic effects may be related to its ability to compete with estrogen for binding sites in target tissues such as breast. Tamoxifen inhibits the induction of rat mammary carcinoma induced by dimethylbenzanthracene (DMBA) and causes the regression of already established DMBA-induced tumors. In this rat model, tamoxifen appears to exert its antitumor effects by binding the estrogen receptors.In cytosols derived from human breast adenocarcinomas, tamoxifen competes with estradiol for estrogen receptor protein.
Absorption and Distribution:
Following a single oral dose of 20 mg tamoxifen, an average peak plasma concentration of 40 ng/mL (range 35 to 45 ng/mL) occurred approximately 5 hours after dosing. The decline in plasma concentrations of tamoxifen is biphasic with a terminal elimination half-life of about 5 to 7 days. The average peak plasma concentration of N-desmethyl tamoxifen is 15 ng/mL (range 10 to 20 ng/mL). Chronic administration of 10 mg tamoxifen given twice daily for 3 months to patients results in average steady-state plasma concentrations of 120 ng/mL (range 67-183 ng/mL) for tamoxifen and 336 ng/mL (range 148-654 ng/mL) for N-desmethyl tamoxifen. The average steady-state plasma concentrations of tamoxifen and N-desmethyl tamoxifen after administration of 20 mg tamoxifen once daily for 3 months are 122 ng/mL (range 71-183 ng/mL) and 353 ng/mL (range 152-706 ng/mL), respectively. After initiation of therapy, steady state concentrations for tamoxifen are achieved in about 4 weeks and steady-state concentrations for N-desmethyl tamoxifen are achieved in about 8 weeks, suggesting a half-life of approximately 14 days for this metabolite. In a steady-state, crossover study of 10 mg NOLVADEX tablets given twice a day vs. a 20 mg NOLVADEX tablet given once daily, the 20 mg NOLVADEX tablet was bioequivalent to the 10 mg NOLVADEX tabletswww.GYMnTONIC.com
Toremifene: Usually dosed around 60 mgs, some dose it up to 240 mgs. Its androgenicity:estrogenicity ratio is 5x that of Nolvadex. It is prescribed to female patients for breast cancer and has shown a high affinity for bonding to the Estrogen receptors in the breast tissue. Male patients treated with toremifene citrate 80 mg compared to placebo demonstrated statistically significant increases in bone mineral density in the lumbar spine, hip, and femur skeletal sites. It decreased the risk by up to 50%. Toremifene citrate 80 mg treatment compared to placebo also resulted in a decrease in total cholesterol, LDL, and triglycerides, and an increase in HDL. There were also statistically significant improvements in gynecomastia. This data are from an ongoing study of men receiving treatment for ADT (androgen depravation therapy). These men are receiving ADT for advanced prostate cancer. ADT removes much of the testosterone and estrogen in the body which helps the prostatic cancer cells grow. So these men were suffering from side effects from reduced estrogen and testosterone in the body. Some studies have even suggested that Torm doesn't regulate progesterone receptors and we may see in the future the possibility of using it with 19-nors.
Toremifene citrate is a selective estrogen receptor modulator (SERM) that is used in bodybuilding to combat gynecomastia and improve muscle growth. It is FDA approved for breast cancer treatment and has shown potential benefits in prostate cancer treatment. Toremifene citrate works by blocking estrogen from interacting with estrogen receptors, leading to an anti-estrogenic effect. This can help prevent gynecomastia and improve muscle growth by maintaining testosterone levels.


